Workup for Chlorine Gas Exposure
Immediately assess respiratory status and oxygen saturation, obtain arterial blood gas (ABG) if symptomatic, perform chest X-ray for moderate-to-severe exposures, and consider pulmonary function testing and bronchoscopy based on severity of presentation.
Initial Assessment and Triage
The workup begins with rapid clinical evaluation focusing on:
- Oxygen saturation (SpO2) - Target 94-98% in most patients 1
- Respiratory rate and pattern - Tachypnea >30/min indicates severe exposure 2
- Presence of respiratory distress - Dyspnea, chest tightness, wheezing
- Ocular and upper airway symptoms - Eye irritation, throat burning, cough
Most patients (>90%) present with cough, dyspnea, and chest discomfort as primary symptoms 3, 2. The severity of initial symptoms guides the depth of workup needed.
Laboratory and Imaging Studies
For All Symptomatic Patients:
Arterial Blood Gas (ABG) should be obtained to assess:
- Oxygenation status (PaO2/FiO2 ratio)
- Presence of respiratory acidosis or metabolic acidosis
- Carbon dioxide retention
Notably, in one study of 41 patients with chlorine exposure who had ABGs performed, all were within normal limits despite symptoms 4. However, ABG remains essential for detecting hypoxemia and guiding oxygen therapy 1.
Chest X-ray is indicated for:
- Patients with persistent respiratory symptoms beyond 6 hours
- Those requiring hospitalization
- Anyone with significant dyspnea or hypoxia
In the research evidence, only 1 of 70 chest X-rays showed positive findings in home exposures 4, but 3 of 12 hospitalized patients developed pulmonary edema 6-8 hours post-exposure 2, highlighting the importance of delayed imaging for moderate-to-severe cases.
For Moderate-to-Severe Exposures:
Pulmonary Function Testing (PFT) should be performed:
- At presentation for hospitalized patients
- Serially during follow-up (at 2,5, and 8 months) 5
Expected findings include:
- Obstructive pattern (FEV1/FVC ratio decreased) in 67% of hospitalized cases 3
- Reduced FVC and peak expiratory flow (PEF) below 80% in 36% of patients 3
- Mixed obstructive-restrictive defects in severe cases 2
Methacholine Challenge Test at 2-month follow-up to detect:
- Bronchial hyperresponsiveness (BHR)
- Reactive Airway Dysfunction Syndrome (RADS) - occurs in up to 25% of hospitalized patients 2, 5
Fiberoptic Bronchoscopy (FB) should be considered when:
- Severe respiratory distress persists
- Suspected bronchial damage or diffuse alveolar hemorrhage
- Clinical deterioration despite treatment
FB allows direct visualization of endobronchial injury and collection of bronchoalveolar lavage fluid for analysis 6. This is particularly valuable when chest imaging and clinical findings don't fully explain the severity of symptoms.
Point-of-Care Ultrasound
Lung ultrasound can rapidly identify:
- B-lines (>3 in bilateral lower lung fields) indicating pulmonary edema
- Useful for monitoring response to treatment 7
This modality provides real-time assessment without radiation exposure and can guide decisions about escalating respiratory support.
Risk Stratification for Workup Intensity
Minimal Workup (Outpatient Management):
- Symptoms resolve within 6 hours
- Normal oxygen saturation on room air
- No respiratory distress
- Workup: SpO2 monitoring, clinical observation
Moderate Workup (Emergency Department):
- Persistent symptoms beyond 6 hours
- Mild hypoxia (SpO2 88-94%)
- Moderate respiratory distress
- Workup: ABG, chest X-ray, PFTs if available
Extensive Workup (Hospitalization):
- Severe hypoxia (SpO2 <88%)
- Respiratory distress requiring oxygen >6 L/min
- Development of pulmonary edema
- Workup: Serial ABGs, chest X-ray (repeat at 6-8 hours), PFTs, consider bronchoscopy, lung ultrasound
Critical Pitfalls
Delayed pulmonary edema: Patients may appear stable initially but develop pulmonary edema 6-8 hours post-exposure 2. Any patient requiring hospitalization needs repeat chest imaging and clinical assessment at this timeframe.
Normal initial chest X-ray: A negative chest X-ray at presentation does not exclude significant lung injury. Clinical symptoms and oxygen requirements should guide management, not imaging alone 4.
Underestimating long-term effects: Obstructive defects and BHR can persist for 8+ months 5. Arrange pulmonary follow-up with serial PFTs at 2,5, and 8 months for all hospitalized patients.
Missing RADS: Up to 25% of hospitalized patients develop RADS 2. Include methacholine challenge testing in follow-up protocols to identify this complication early.
The workup intensity should match exposure severity, but maintain a low threshold for comprehensive evaluation given the potential for delayed complications and long-term respiratory dysfunction.